Related references
Note: Only part of the references are listed.Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia
Jihane Fattoum et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age
Paola Finsinger et al.
ANNALS OF HEMATOLOGY (2015)
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
Sylvain Thepot et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)
Jakob R. Passweg et al.
LEUKEMIA & LYMPHOMA (2014)
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
Heidi D. Klepin et al.
BLOOD (2013)
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
Lieke H. van der Helm et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Hagop M. Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
Mikkael A. Sekeres et al.
BLOOD (2011)
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
Lionel Ades et al.
BLOOD (2010)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
Hagop Kantarjian et al.
BLOOD (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
Jean-Luc Harousseau et al.
BLOOD (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Comprehensive geriatric assessment for older patients with cancer
Martine Extermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
Alan K. Burnett et al.
CANCER (2007)
Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit
Kellie L. Flood et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia
A Wahlin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
